Abstract
Genetic alterations in the Wnt/β-catenin/TCF-signaling pathway are commonly found in human tumors, but not in glioblastomas. In this issue of Cancer Cell, Zhang et al. report that FoxM1 mediates β-catenin nuclear translocation in glioblastoma, suggesting a novel mechanism for glioblastoma progression in the absence of conventional Wnt/β-catenin pathway activation.
Original language | English |
---|---|
Pages (from-to) | 415-416 |
Number of pages | 2 |
Journal | Cancer Cell |
Volume | 20 |
Issue number | 4 |
DOIs | |
State | Published - Oct 18 2011 |